Cargando…

Early 2 factor (E2F) transcription factors contribute to malignant progression and have clinical prognostic value in lower-grade glioma

Early 2 factor (E2F) genes encoding a family of transcription factors are significantly associated with apoptosis, metabolism, and angiogenesis in several tumor types. However, the biological functions of E2F transcription factors (E2Fs) and their potential involvement in the malignancy of lower-gra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Haitao, Tao, Chuming, Long, Xiaoyan, Zhu, Xingen, Huang, Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806968/ https://www.ncbi.nlm.nih.gov/pubmed/34617871 http://dx.doi.org/10.1080/21655979.2021.1985340

Ejemplares similares

Protein disulphide isomerase can predict the clinical prognostic value and contribute to malignant progression in gliomas
por: Hu, Qing, et al.
Publicado: (2020)

A risk signature of four aging-related genes has clinical prognostic value and is associated with a tumor immune microenvironment in glioma
por: Luo, Haitao, et al.
Publicado: (2021)

Prognostic and Predictive Value of Immune-Related Gene Pair Signature in Primary Lower-Grade Glioma Patients
por: Lei, Kunjian, et al.
Publicado: (2021)

N6-Methylandenosine-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Lower-Grade Glioma Patients
por: Tu, Zewei, et al.
Publicado: (2020)

Integrin Alpha-2 as a Potential Prognostic and Predictive Biomarker for Patients With Lower-Grade Glioma
por: Lin, Li, et al.
Publicado: (2021)

Development of a prognostic index based on immunogenomic landscape analysis in glioma
por: Luo, Haitao, et al.
Publicado: (2021)

Comprehensive analysis of the prognostic and role in immune cell infiltration of MSR1 expression in lower‐grade gliomas
por: Ji, Qiankun, et al.
Publicado: (2022)

Transcriptional Patterns of Lower-Grade Glioma Patients with Distinct Ferroptosis Levels, Immunotherapy Response, and Temozolomide Sensitivity
por: Tu, Zewei, et al.
Publicado: (2022)

Intrinsic immune evasion patterns predict temozolomide sensitivity and immunotherapy response in lower-grade gliomas
por: Tu, Zewei, et al.
Publicado: (2022)

Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma
por: Tao, Chuming, et al.
Publicado: (2021)

Immune Characteristics and Prognosis Analysis of the Proteasome 20S Subunit Beta 9 in Lower-Grade Gliomas
por: Liu, Junzhe, et al.
Publicado: (2022)

Establishment and validation of a novel prognostic model for lower-grade glioma based on senescence-related genes
por: Li, Junsheng, et al.
Publicado: (2022)

Systematic and Multi-Omics Prognostic Analysis of Lysine Acetylation Regulators in Glioma
por: Tu, Zewei, et al.
Publicado: (2021)

Expression and prognostic role of E2F transcription factors in high‐grade glioma
por: Yu, Hai, et al.
Publicado: (2020)

Transcriptomic Analysis of Glioma Based on IDH Status Identifies ACAA2 as a Prognostic Factor in Lower Grade Glioma
por: Wu, Chenxing, et al.
Publicado: (2020)

Development and validation of a leukocyte‐associated immunoglobulin‐like receptor‐1 prognostic signature for lower‐grade gliomas
por: Fang, Zhansheng, et al.
Publicado: (2022)

WHO Grade Loses Its Prognostic Value in Molecularly Defined Diffuse Lower-Grade Gliomas
por: Carstam, Louise, et al.
Publicado: (2022)

DNA demethylation is associated with malignant progression of lower-grade gliomas
por: Nomura, Masashi, et al.
Publicado: (2019)

Genomics and Prognosis Analysis of Epithelial-Mesenchymal Transition in Glioma
por: Tao, Chuming, et al.
Publicado: (2020)

Prognostic Value of Immune-Related lncRNA SBF2-AS1 in Diffuse Lower-Grade Glioma
por: Zhang, Qiang, et al.
Publicado: (2021)

ADAM9 Expression Is Associate with Glioma Tumor Grade and Histological Type, and Acts as a Prognostic Factor in Lower-Grade Gliomas
por: Fan, Xing, et al.
Publicado: (2016)

Lower Grade Gliomas
por: Youssef, Gilbert, et al.
Publicado: (2020)

Validation of the functions and prognostic values of synapse-associated proteins in lower-grade glioma
por: Lin, Han, et al.
Publicado: (2021)

Prognostic Value of a Stemness Index-Associated Signature in Primary Lower-Grade Glioma
por: Zhang, Mingwei, et al.
Publicado: (2020)

Prognostic Value of an Autophagy-Related Five-Gene Signature for Lower-Grade Glioma Patients
por: Guo, Jin-Cheng, et al.
Publicado: (2021)

The Prognostic and Immunological Value of Guanylate-Binding Proteins in Lower-Grade Glioma: Potential Markers or Not?
por: Liu, Zhuang, et al.
Publicado: (2021)

Prognostic value of γ‐aminobutyric acidergic synapse-associated signature for lower-grade gliomas
por: Jiang, Hongxiang, et al.
Publicado: (2022)

Publisher Correction: DNA demethylation is associated with malignant progression of lower-grade gliomas
por: Nomura, Masashi, et al.
Publicado: (2019)

CCR5 as a Prognostic Factor in Lower-Grade Glioma is Involved in the Remodeling of the Tumor Microenvironment
por: Wang, Fang, et al.
Publicado: (2022)

Prognostic Factors of Low-Grade Gliomas in Adults
por: Deacu, Mariana, et al.
Publicado: (2022)

Identification of RNA: 5-Methylcytosine Methyltransferases-Related Signature for Predicting Prognosis in Glioma
por: Wang, Peng, et al.
Publicado: (2020)

Resilience in Lower Grade Glioma Patients
por: Fröhlich, Ellen, et al.
Publicado: (2022)

Preclinical modeling of lower-grade gliomas
por: Tang, Lilly W., et al.
Publicado: (2023)

SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomas
por: Wang, Peng, et al.
Publicado: (2020)

EGFR mutation: novel prognostic factor associated with immune infiltration in lower-grade glioma; an exploratory study
por: Hao, Zhaonian, et al.
Publicado: (2019)

TP53 Mutation Is a Prognostic Factor in Lower Grade Glioma and May Influence Chemotherapy Efficacy
por: Noor, Humaira, et al.
Publicado: (2021)

YTHDF2 correlates with tumor immune infiltrates in lower-grade glioma
por: Lin, Xiangan, et al.
Publicado: (2020)

Clinicopathological analysis of T2-FLAIR mismatch sign in lower-grade gliomas
por: Deguchi, Shoichi, et al.
Publicado: (2020)

Identification of Critical m(6)A RNA Methylation Regulators with Prognostic Value in Lower-Grade Glioma
por: Zheng, Jianglin, et al.
Publicado: (2021)

Integrated Analysis Reveals Prognostic Value and Immune Correlates of CD86 Expression in Lower Grade Glioma
por: Qiu, Huaide, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lmeo6rpv1ok8dh3pgip04trs9o